Drawing for EKOS

USPTO serial 86614412

EKOS

Reviewed by CopyMark Law Group

Reg. 6295368Status 700Renewal
Filing date
Status date
Registration date
Mar 16, 2021
Examiner
KHOURI, SANI PHILIPPE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EKOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori A. Ruhly

Lori A. Ruhly Quarles & Brady LLP33 East Main Street, Suite 900Madison, WI 53703United States

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware and software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; computers; computer hardware and software for medical imaging apparatus; computer installations, apparatus and instruments, namely, computer software and associated computer hardware for use in collecting, storing, managing, processing, communicating and reporting of data obtained from medical devices, medical related devices and input devices to which the hardware interconnects; computer imaging systems comprising computer hardware and software for medical imaging apparatus; computer software and computer programs in the field of ultrasounds and medical devices for controlling and operating medical devices and ultrasound apparatus; computer software for use in the medical and pharmaceutical fields for use in the operation of medical devices and ultrasound equipment; computer software for use in medical devices for processing, analyzing and displaying images and reports from these medical devices; computer software and computer programs providing information to medical professionals and patients; computer hardware; electric and electronic control systems for controlling medical apparatus and instruments; electric and electronic control systems for controlling apparatus for generating and transmitting ultrasound; data processing apparatus and computers for controlling medical apparatus and instruments; data processing apparatus and computers for controlling apparatus for generating and transmitting ultrasound; computer software for controlling medical apparatus and instruments; computer software for controlling apparatus for generating and transmitting ultrasound; stands for computer equipment; medical software for processing and displaying images on ultrasound medical imaging apparatus; medical imaging software that records, monitors and analyses data using an ultrasound imaging probe; medical workstation comprised of computer hardware and software for gathering and transmitting patient image data for use during surgical procedures; software for processing digital images of the anatomy for diagnosis and treatment; software for medical imaging; equipment for scientific research, namely, ultrasound imaging systems comprising ultrasound scanners, ultrasound imaging devices, and ancillary equipment sold as a unit; computer software for use in relation to ultrasound imaging and scanning; parts and fittings for all the aforesaid goodsACTIVEMay 12, 2008
010Medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, and intracranial hemorrhages, cerebral hemorrages, and hematoma; medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, and intracranial hemorrhages, cerebral hemorrages, and hematoma and software sold as a unit therewith; drug delivery apparatus and instruments, namely, ultrasonic medical apparatus; drug delivery apparatus and instruments, namely, ultrasonic medical apparatus and software sold as a unit therewith; drug delivery systems; surgical and medical apparatus and instruments for use in treatment of the circulatory system; medical apparatus and instruments for use in the prevention and treatment of the circulatory system issues and conditions, vascular issues and conditions, and intracranial hemorrhages, cerebral hemorrages, and hematoma; medical devices which use ultrasound to enhance drug delivery and medically activate drugs; catheters for delivery of drugs and fluids and controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus and controllers and power units therefor; catheters; parts and fittings for all the aforesaid goods; equipment for medical diagnosis, namely, ultrasound imaging systems comprising ultrasound scanners, ultrasound imaging devices, and ancillary equipment sold as a unit; imaging apparatus, namely, medical imaging apparatusACTIVESep 28, 1998

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 16, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 3, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 3, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 3, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 3, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 3, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 16, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 16, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 16, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 16, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 16, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 26, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 21, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 21, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 21, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 21, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 21, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 16, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 9, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 8, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 22, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 18, 2021IUAFUSE AMENDMENT FILED—
Jan 18, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 26, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 26, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 26, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Oct 26, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 26, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 26, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 28, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 27, 2020EX5GSOU EXTENSION 5 GRANTED—
Jul 23, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 6, 2020EXT5SOU EXTENSION 5 FILED—
Jul 6, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 17, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 15, 2020EX4GSOU EXTENSION 4 GRANTED—
Jan 15, 2020EXT4SOU EXTENSION 4 FILED—
Jan 15, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 15, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 13, 2019EX3GSOU EXTENSION 3 GRANTED—
Jun 13, 2019EXT3SOU EXTENSION 3 FILED—
Jun 13, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 25, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 23, 2018EX2GSOU EXTENSION 2 GRANTED—
Oct 23, 2018EXT2SOU EXTENSION 2 FILED—
Oct 23, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 14, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 12, 2018EX1GSOU EXTENSION 1 GRANTED—
Jul 12, 2018EXT1SOU EXTENSION 1 FILED—
Jul 12, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 16, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 22, 2017CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Nov 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2017APETASSIGNED TO PETITION STAFF—
Nov 6, 2017EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 19, 2017FIXDELECTRONIC RECORD REVIEW COMPLETE—
Oct 13, 2017ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Oct 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 21, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 21, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 18, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 29, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 8, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 23, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 29, 2016GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 29, 2016GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 29, 2016CNSISUSPENSION INQUIRY WRITTEN—
Aug 8, 2016RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Feb 2, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 2, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Feb 2, 2016CNSLSUSPENSION LETTER WRITTEN—
Jan 16, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 15, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 15, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 15, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2015DOCKASSIGNED TO EXAMINER—
Jun 8, 2015AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jun 1, 2015ALIEASSIGNED TO LIE—
May 26, 2015PARITEAS VOLUNTARY AMENDMENT RECEIVED—
May 11, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 2, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance